These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12807165)

  • 1. Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma.
    Tinkelman DG; Bronsky EA; Gross G; Schoenwetter WF; Spector SL
    J Asthma; 2003 May; 40(3):225-36. PubMed ID: 12807165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
    Shapiro G; Bronsky EA; LaForce CF; Mendelson L; Pearlman D; Schwartz RH; Szefler SJ
    J Pediatr; 1998 Jun; 132(6):976-82. PubMed ID: 9627589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids.
    Metzger WJ; Hampel FC; Sugar M
    J Asthma; 2002 Feb; 39(1):65-75. PubMed ID: 11883741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
    Nelson HS; Bernstein IL; Fink J; Edwards TB; Spector SL; Storms WW; Tashkin DP
    Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group.
    Miyamoto T; Takahashi T; Nakajima S; Makino S; Yamakido M; Mano K; Nakashima M; Tollemar U; Selroos O
    Respirology; 2000 Sep; 5(3):247-56. PubMed ID: 11022987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma.
    Kuna P; Joubert JR; Greefhorst LA; Magnussen H
    Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Japanese Pulmicort Turbuhaler study group.
    Miyamoto T; Takahashi T; Nakajima S; Makino S; Yamakido M; Mano K; Nakashima M; Tollemar U; Selroos O
    Respirology; 2000 Sep; 5(3):231-40. PubMed ID: 11022985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma.
    Banov C; Howland WC; Lumry WR; Parasuraman B; Uryniak T; Liljas B
    Allergy Asthma Proc; 2003; 24(2):129-36. PubMed ID: 12776447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia.
    Chuchalin AG; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Int J Clin Pract; 2002; 56(1):15-20. PubMed ID: 11833550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
    J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings.
    Weiss KB; Liljas B; Schoenwetter W; Schatz M; Luce BR
    Clin Ther; 2004 Jan; 26(1):102-14. PubMed ID: 14996523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
    Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
    JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
    Bousquet J; D'Urzo A; Hebert J; Barraza CH; Boulet LP; Suárez-Chacón R; Harnest U; Lundbäck B; Martinez Morales G; Nieminen MM; Nolop KB; Visser S; Lutsky BN
    Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study.
    Sheffer AL; Silverman M; Woolcock AJ; Díaz PV; Lindberg B; Lindmark B
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):48-54. PubMed ID: 15702816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.